current affairs
Issue 274, 6th October – 2nd November 2026
This newsletter is sponsored by Natural Product Centre, a full service consultancy that can take your product concept and develop it into a compliant product ready to launch. See below for details of advice on new labelling laws.

CONTENTS
Training news
Complementary medicines and medical devices
Foods
Cosmetics and sunscreens
ACCC and other news
Training news
Regulatory Training Direct is an online training organisation with a focus on regulatory compliance and related topics.
New labelling laws
The new labelling law is now in place and all labels must comply by 1 October 2031. COMPANIES OUTSIDE OF AUSTRALIA who are selling products here please take note, this is important! Our new course 1.04 Listed medicine labels – advanced is for people that already have some knowledge of the previous listed medicine labelling laws TGO 92 and need to know about compliance with the new labelling order TGO 116. The agenda includes:
• Regulatory context
• TGO 116 transition period
• Critical differences between TGO 92 and TGO 116
• Changes to make compliance easier
• Other types of changes
• Sunscreens and TGO 116
• Deferred changes
• Guidance
• Top tips on getting through the transition period
• Section 14 consents
• Where to get help
This course has not been pre-recorded as some details of the labelling requirements are yet to be finalised. To book the live Zoom course please go here and make an appointment so our senior trainer can go though the course notes with you and answer your questions.
Our original labelling course has been revised and renamed as 1.03. Listed medicine labels – introduction. You can read the agenda and book the course here.
We also provide other courses on complementary medicines compliance and:
– advertising
– medical devices
– foods
– cosmetics
– pharmacovigilance
– New Zealand cosmetics and dietary supplements
– USA dietary supplements, cosmetics and medical devices
View the agenda for all 40 courses and book online here. Some courses are available as live tuition, others are eLearning (pre-recorded), and some are available in both formats. When you purchase an eLearning course your password lasts for 60 days, so you can access the course as often as you want before the password expires
Regulatory affairs news
Complementary Medicines and Medical Devices
Update to ingredients permitted in listed medicines. Listed medicines do not only include most complementary medicines, but also primary sunscreens and some other medicines. Updated 16 October. Read about the changes here – 5 ingredients added and 5 have changes. See the updated list of permitted ingredients here – sorted alphabetically into volumes.
Consultations:
* TGA seeking feedback on whether the current exclusion for certain digital mental health tools (DMHTs) DMHTs should be kept, removed or modified. Digital mental health tools (DMHTs) include apps, websites and chatbots that provide assessment, therapy or self-management strategies for mental health conditions. Closes 7 December. Read more here
* Vitamin B6 – proposed changes to the list of ingredients permitted in listed complementary medicines containing pyridoxine hydrochloride, pyridoxal 5-phosphate and pyridoxal 5-phosphate monohydrate. Four label statements are proposed. Closes 25 November. Read more here
* Proposed changes to permissible ingredient list: 1. Myristica fragrans use during pregnancy and lactation, and 2. Requirements relating to amygdalin and hydrocyanic acid. Read an overview here and the full consultation paper is here. Closes 14 December.
Advisory Committee on Complementary Medicines – meeting statement from 30 July meeting. Topics discussed included Withania somnifera and Andrographis paniculata. Read the statement here.
Compositional guidelines for ingredients permitted in listed medicines
* Bacillus coagulans strain ATCC PTA-126829 – read it here.
* Gamma glutamylcysteine (γ-GC) is a dipeptide of L‑cysteine and L-glutamic acid linked through the gamma (γ)‑carboxyl group of glutamic acid. Published here.
* Hydrocarbons, C6-C20, polymers, hydrogenated – is here
* Magnesium L-threonate monohydrate is a magnesium salt of L‑threonic acid. Guideline is here.
* Mitoquinol mesilate – here
* Styrene/isoprene/styrene block copolymer is here
TGA licensed manufacturers
* Decisions relating to the granting of licences updated 12 October here.
AUST numbers on medicine labels – updated guidance as at 8 October, here.
TGA’s freedom of disclosure (FOI) log – last updated 28 October, is here.
Clinical trials
* regulations are being updated – see here. and also here for info in the National One Stop Shop for clinical trials
* Human Research Ethics Committee (HREC) and TGA Clinical Trials Discussion Forum held in October – presentations summarised here
* Guidance about how Clinical Decision Support System (CDSS) software is regulated. Find out when this software is exempt from inclusion in the Australian Register of Therapeutic Goods. More here
Medicines and medical devices that have been cancelled at the request of the sponsor: updated 30 October, published here.
Compliance activity – Compliance enforcement
* Infringement notices: a list of infringement notices issued in response to breaches, updated 6 October published on this webpage
* The Federal Court has ordered CDA Clinics and Dr Benjamin Jansen to pay $6.5 millionin civil penalties for the unlawful advertising of medicinal cannabis for the treatment of cancer, mental illnesses, autoimmune conditions, fibromyalgia, chronic pain, seizures, meningitis and autism. Read more here.
* TGA, Queensland Health and the Queensland Police Service targeted the alleged unlawful storage and distribution of illicit vaping goods, illicit tobacco and unapproved nicotine products. More here.
* More than $126,000 in infringement notices for unlawful importation and advertising of prescription-only medicines issued to 2 companies and 5 individuals – the infringement notices have all been paid. Details here.
.
Advertising Compliance Investigations Outcome – published here
Listed medicine compliance report – no updates since last newsletter (30 Sep update)
Instruments – a large number of “instruments” affect many products and there is a summary of them all here
Court actions resulting in criminal prosecutions – updated 30 October here.
Recalls
* Recall coordinators – state, territory and national recall coordinators revised contact details are here.
* Andrographis: list of products recalled due to risk of severe allergic reaction – updated 30 October – over 40 products listed here.
Importing therapeutic goods
* do you want to import a product that does not comply with certain standards? You may be able to apply for consent. Read how here.
* Search consents to import, supply or export therapeutic goods that do not comply with standards – here
Updated guidance: regulatory requirements for supplying therapeutic goods that contain, or are produced from, human plasma – find it here
Vaping: Notified vape list, goods for smoking cessation or nicotine dependence that can legally be supplied, updated 2nd October here.
Unapproved nicotine gum products – TGA warns that nicotine is highly addictive and can be harmful to health, and should be kept out of the reach of children. Read more here.
Submitting data in Electronic Common Technical Document (eCTD) format – updated guide here – How to submit applications, reports and documentation updated guide here
Medical devices
Digital scribes
* Outcome of the review of digital scribes supplied in Australia, summary here full documents here.
* When are digital scribes regulated as medical devices. Digital scribes (also referred to as artificial intelligence (AI) scribes, ambient scribes or ambient voice technology) are increasingly used in clinical settings to capture conversations between patients and healthcare practitioners. These tools generate clinical notes, summaries, letters or other outputs, which may be added to patient records. Information here.
Updated form for approval of a new Technical Master File (TMF), an annual update to an approved TMF, or a significant update to an approved TMF. is available here
Updated Guideline: Preparing and maintaining a Technical Master File (TMF) is available here
Review of the exclusion for certain digital mental health tools – in progress. Read the findings as at 19 October here.
Two webinars on digital mental health tools are being held on the 10 November and 18 November. Details here.
UDI for healthcare – how healthcare organisations can prepare for and adopt UDI. Updated 29 October.
UDI news and updates as of 29 October, here.
Latest enhancements and fixes to the Australian UDI Database are here
Overview for healthcare – Learn how to use the Australian Unique Device Identification Database (AusUDID) and understand the information shown in the database. Updated 28 October, here.
EU MDR transition publication service – updated 26 October information here.
Dealing with the TGA – updating or adding an organisation administrator – new form is available here.
Botanical Adulterants Prevention Programme (BAPP) and similar articles supplied by Michael D. Levin of Health Business Strategies LLC
* Lemon balm (Melissa officinalis, Lamiaceae) is a popular medicinal herb commonly consumed as a tea for its calming effects and to promote sleep. Nine commercial samples were analysed but four were found to be lemon verbena (Aloysia citrodora) Read more here
* Comprehensive high-performance thin-layer chromatography analysis of Monteverdia ilicifolia leaf and its adulterants – published here.
* BAPP webinar – 𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐨𝐦𝐢𝐜 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐭𝐨 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐂𝐨𝐧𝐭𝐫𝐨𝐥. register here
* Saw Palmetto common adulterants – by Kerry Hughes, on Linkedin here.
For regular news on US dietary supplement and food regulation, go to AWG Regulatory Roundup.
IN THE PRESS
* Coroner recommends TGA review peptide restrictions after Australian actor’s death. ”
He collapsed and suffered a cardiac arrest after injecting the products, which a doctor had prescribed to him. In findings delivered on Wednesday, Mr Ryan said Norton “had been taking amounts of the medication in excess of the dose prescribed by his medical practitioner”. Published on abc.net.au
* Why are unapproved peptides still allowed to be prescribed by doctors? Also on abc.net.au
* and ‘Enormous surge’ in peptide use forces needle and syringe programs to restrict safe injecting resources. abc.net.au
Foods
Food Standards Code Compilation was updated in October – available here.
FSANZ Work Plan – download here.
FSANZ Board held an extraordinary meeting on 6 October 2026. The communique is here and approved Application A1341 to permit cell-cultured duck biomass to be used as a food ingredient. The biomass is produced from cells derived from Pekin duck and is intended to be combined with other ingredients in products such as ‘cell-cultured foie gras’ and ‘cell-cultured duck pâté’.
New applications and proposals
* A1367 – Cellulase from Trichoderma reesei (gene donor: Aspergillus niger) for use as a processing aid
* A1366 – To permit the sale and use of Rhizomucor pusillus mycelium as a novel food
Public consultations and calls for submissions/comments on proposed variations to the Code arising from the following submissions:
* A1325 – Use of steviol glycosides as a food additive in hot plate flour products – closes 11 November
* A1358 – Glucoamylase from Trichoderma reesei (gene donor: Aspergillus fumigatus) for use as a processing aid – closes 24 November
* A1356 – Food derived from increased nicotianamine wheat lines containing event UM-12115T-1 – closes 1 December
* P1067 – Health Star Rating System – closes 23 December
2026 Maximum residue limit harmonisation proposal [Australia only] – is now open and can be read here, Requests must be lodged 6 pm (Canberra time) Friday 29 January 2027.
Amendment 253 to food standards code published here
A1306 – Chitosan from mushrooms (Agaricus bisporus) for use as a processing aid
A1338 – Triacylglycerol lipase from Komagataella phaffii (gene donor: Yarrowia lipolytica) for use as a processing aid
A1345 – Dextransucrase from Bacillus subtilis (gene donor: Streptococcus salivarius) for use as a processing aid
Novel foods determinations – updated in September – available here, includes
Miracle Berry Powder (Synsepalum dulcificum) – determined to be a Non-traditional food
and a Novel food. Reason: No tradition of use of berry powder from Synsepalum dulcificum in Australia and New Zealand. Safety not established. Requires assessment of potential allergenicity. Note: this view relates to freeze-dried powder produced from the pulp of the berry with skin and seeds removed during processing.
Update as at 16 October: The Advisory Committee on Novel Foods (ACNF) is undergoing review. While the review is underway, the committee is not considering new enquiries. Source: FSANZ
Recalls
* Coca-Cola Europacific – Pump Spring Water – Packaging fault: There is a risk of the white sipper dislodging causing a potential choking hazard. FSANZ
* Maria’s Pasta – various products – Foreign matter (metal) FSANZ
* Atomic Changes – Bomberry – four products (blueberries and raspberries in chocolate) – foreign matter (metal). FSANZ
* ALOG AUSTRALIA – Maruto Nagasaki Castella cake – undeclared allergens (egg and soy). FSANZ
* Arla Protein Salted Caramel Flavour Pudding & Arla Protein Chocolate Flavour Pudding – foreign matter (glass). FSANZ
* ALDI Stores – Farmdale Full Cream Long Life Milk – microbial contamination (spoilage). FSANZ
* Tweedvale Dairies Reduced Fat Milk – Microbial (E. coli) contamination. FSANZ
* Nissin Salt and Sesame Oil Noodles Aburasoba – undeclared allergen (Milk). FSANZ
Updated requirements for importing kava as a food – including the labelling restrictions on nutrition content claims and health claims. Source: Department of Agriculture, Fisheries and Forestry
Stay up to date with Food News by subscribing to The Correct News, published by Correct Food Systems.
AI in Food Safety – interesting thoughts published by Karen Constable and Is food fraud increasing? read it at https://therottenapple.substack.com/
New Zealand Food safety insights, emerging risks, and current issues bulletins: 19th October issue can be viewed here (always an interesting read!).
New Zealand food recalls
* Woolworths Potato Long Roll – undeclared allergen (soy). NZ MPI
* Arla Protein Pudding Vanilla Cookie – foreign matter (glass fragments) NZ MPI
* Back Country Cuisine – Sticky Date and Custard – undeclared allergens (gluten and wheat) NZ MPI
Cosmetics and sunscreens
Sunscreen reforms – a summary of work in progress, including
* Strengthen sunscreen testing requirements
* Develop specific ingredient quality requirements
* Provide a consistent limit for SPF rating that can be claimed for all secondary (cosmetic) sunscreens
* Review sunscreen good manufacturing practice (GMP) guidance
* Consideration of labelling for SPF ratings
Summary of progress to date, published 27 October, is here.
TGA strengthening sunscreen regulation to improve confidence in Sun Protection Factor (SPF) claims – this is very similar to what is included in the above link .. this one is here
Guideline: how to choose a sunscreen, use it correctly, report a problem and learn how TGA regulates sunscreens. 27 October update is here.
Consumer NZ Sunscreen Testing – The TGA is aware of recent sunscreen testing undertaken by Consumer NZ, which reported Sun Protection Factor (SPF) results for a number of sunscreens. Source: TGA
Safety concerns with cosmetic nail glue – see story below under ACCC
PFAS introduction and use in Australia: draft evaluation statement open for comments until 2 December 2026, closes 2 December, read about it here.
Do you need to submit a post-introduction declaration (PID) for 2025–26? You must submit a post-introduction declaration if you introduced a chemical under one of these exempted categories for the first time between 1 September 2025 and 31 August 2026. Due date is 30 November. More here.
The Australian Inventory of Industrial Chemicals – the latest snapshot of the inventoryis here
Submit your annual declaration for 2025–26 by 30 November 2026. All introducers (importers or manufacturers) must submit the 2025–26 annual declaration if they introduced any industrial chemicals for commercial purposes between 1 September 2025 and 31 August 2026. More info here.
Draft evaluations open for comment – 7 draft evaluations, closes 26 November, see the list here.
How to find a chemical assessment – go here
Variation to Inventory listing – as at 8 October – one chemical CAS 98969-19-8 Benzoic acid, 2-hydroxy-, 2-methylpentyl ester – details here
Completed evaluations none this month
Commercial evaluation authorisations – none this month
Correction of chemical names on the inventory: as at 26 October – a large number – find them here.
Chemical added to the Inventory following issue of assessment certificate – none this month
Chemicals added to the Inventory 5 years after issue of assessment certificate (obligations to provide information apply): none this month
Industrial Chemicals Regulatory News – nothing published since 29 July
Additional EU cosmetics regulations news provided by Amandine Perez, AP Cosmetic Consult
* The UV filter OCTOCRYLENE : https://www.linkedin.com/feed/update/urn:li:activity:7515653250621104130
* The ingredient RESORCINOL : https://www.linkedin.com/feed/update/urn:li:activity:7518189793839706113
* regulatory memo summarizing recent european regulatory changes and their deadlines. https://www.linkedin.com/feed/update/urn:li:activity:7513116080949714945
Cosmetics Consultants Europe (CCE),
Cosmetics Consultants Europe’s (CCE) Online Practical Training for Safety Assessment
Two Topics for the Price of One!
Live Event Topics with Q/A
Tues., 10. Nov., ‘Exposure Scenarios’
Tues., 8. Dec., ‘Safety Margins’
Speakers
Dr. Ulrich Eicken, Managing Dir., Eicken Safe Cosmetics, Switzerland
Dr. Uwe Rossow, Managing Dir., CCR GmbH, Germany
Time Zones: 12EST 17GMT 18-19.30CET 19EET
Register/Contact: Steven L. Hanft, Business Development, CCE
steven.hanft@conusbat.com | www.ccecosmetic.org/cce-training-courses/
Code: 2 Seminars. More information, email steven.hanft@conusbat.com.
IN THE PRESS
Urgent warning over ‘backyard’ Sydney cosmetic procedures – Patients who visited an unregistered provider of cosmetic and medical procedures in Sydney may have been exposed to hepatitis B, hepatitis C and HIV. A shocking article published on www.abc.net.au
ACCC and other news
ACCC has commenced Federal Court action against Kmart Australia, alleging it breached the Australian Consumer Law by selling millions of units of cosmetic nail glue without adequate warnings and thousands of units of button battery products which did not comply with mandatory standards. Source: ACCC
Australia’s biggest egg supplier Sunny Queen and 11 other egg producers and suppliers are alleged to have breached competition laws including production volumes, distribution, expansion plans and culling to manage perceived oversupply, ACCC
Perfection Fresh admits to fixing the price of vegetables sold to ALDI ACCC
ACCC publishes a newsletter Product safety Matters – you can subscribe here.
Other news
New Zealand Ministry for Regulation exists to improve how regulation works for New Zealanders. The Annual Report 2025/26 states “We delivered significant regulatory reforms, system improvements and capability initiatives designed to reduce unnecessary regulatory burden, improve the quality of regulation, and strengthen the performance of regulatory systems across government.”. Read more here.
Sponsored article – Natural Product Centre
New labelling laws for complementary medicines in Australia are now in place. The Therapeutic Goods (Standard for Labelling of Non-Prescription Medicines) (TGO 116) Order 2026. TGO 116 replaces TGO 92.
NPC has been actively involved in the consultation, is abreast of key changes and has developed a robust SOP [Standard Operation Procedure] to undertake label compliance reviews in accordance with the new regulations.
The new regulations have several more lenient provisions which will benefit you as the sponsor. However, there are also some stricter provisions on how, what and where information is displayed. TGA has agreed to an extended transition period of five years. This means, all complementary medicines released for supply from 1 October 2031 must comply with TGO 116. You should act as soon as possible to leverage the more lenient provisions, to allow time to manage existing label inventory, and request/ create necessary updates to supporting documentation from contract manufacturers (and suppliers) to ensure compliance with the new regulations prior to 1 October 2031.
Clients of NPC can utilise label compliance review services for all existing and new complementary medicines at a special set rate. New clients seeking to engage NPC for a label compliance review or other regulatory services can do so through NPC’s onboarding form.
Published by Regulatory Training Direct www.regulatorytrainingdirect.com
Providing regulatory training courses for complementary medicines, medical devices, GMP, foods, cosmetics, dietary supplements.
Comments? Contact the editor Robert Forbes via this link.
This newsletter is sent at no charge. You are welcome to forward this to any colleagues who may find it useful. To receive this newsletter regularly click this link



